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Abstract In this revision a summary of the trends of the formation of complex 
or not so complex heterocyclic structures through 1,3-DC of azomethine ylides 
is described. Diastereo- and enantioselective processes as well as non-
asymmetric cycloadditions constitute very important synthetic tools for 
achieving all these series of compounds. The contents are classified as follows: 
1. Introduction  
2. Synthesis of spiroxindoles  
3. Synthesis of spiropyrrolidines  
4. Synthesis of spiropiperidines and piperidines  
5. Synthesis of pyrrolidines and fused pyrrolidines  
6. Synthesis of pyrrolizidines and indolizidines  
7. Synthesis of quinolone and isoquinolines  
8. Conclusions 
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Biomimetic studies and biosynthetic theories strongly support 
that general [3+2] cycloadditions1 take place frequently in 
nature.2 In this line, azomethine ylides are useful synthetic 
intermediates to access complex molecules, and in consequence, 
their precursors are valuable building blocks in the elaboration 
of structurally diverse biologically important heterocycles and 
natural products.  The main utility of these dipolar intermediates 
is as component of 1,3-dipolar cycloaddition (1,3-DC) together 
with electrophilic alkenes. Inter- and intramolecular versions of 
these types of 1,3-DCs provide a potentially flexible and versatile 
entry into the complex molecular framework with a pyrrolidine 
core. These cycloadditions reach a special dimension when the 
catalytic enantioselective process is successfully implemented. In 
this way, up to four contiguous stereogenic centers can be 
unambiguously generated in just one single step.  
 There are many excellent reports and reviews in the literature 
about the generation, and applications concerning 1,3-DCs with 
azomethine ylides but this field is in continuous expansion.3 In 
this review the literature from 2015 through 2016 was covered 
organizing the research in terms of biologically important 
heterocycles and natural product from cascade 1,3-DC of 
azomethine ylide to the most simple cycloaddition [the 
application of this strategy to the generation of new materials or 
polymers is not covered in this review]. 
 
 
2. Synthesis of spirooxindoles  
 
Spirooxindole skeleton has an important biological role in 
bioorganic and medicinal chemistry as well as in the drug 
discovery programs.4 Synthesis of novel potentially bioactive 
spirooxindoles has been reviewed in a recent paper and the work 
related to spirooxindolepyrrolidines was also detailed.5 
However, in this review some very recent publications have not 
been highlighted. Therefore, in this revision the most recent work 
regarding to spiroxindolepyrrolidines, obtained from a 
multicomponent 1,3-dipolar cycloaddition (1,3-DC) of 
azomethine ylides with the appropriate alkene, is reported.  
The synthesis of spirooxindolepyrrolizidine derivatives 4 and 4’, 
as well as their in vitro bioactivity against Mycobacterium 
tuberculosis, were reported by Askri et al. Compounds 4 and 4’ 
were prepared from non-stabilized azomethine ylides, generated 
in situ from isatin derivatives 2 and L-proline 1. Subsequent 1,3-
DC with (E,E)-1,3-bis(arylidene)indan-2-ones 3 yielded the 
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corresponding dispirooxindolepyrrolizidines in a one-pot three 
component domino reaction with poor diastereoselectivities 
(Scheme 1).6, 7 In general, in these type of cycloadditions 
regarding iminium-decarboxylation route, the iminium salt I 
formed between compounds 1 and 2 undergoes a spontaneous 
decarboxylation to give the intermediate azomethine ylide II, 




Scheme 1 Synthesis of diastereomeric mixtures of spirooxindoles 4 and 4’. 
 
An environmentally friendly synthesis of spirooxindolo-
pyrrolizidines 6 was reported by Tiwari et al. starting from 
proline 1, isatins 2, and acrylonitrile or methylacrylate in water. 
The reaction proceeded regioselectively in a three-component 
manner. Again, the in situ generation of fleeting non-stabilized 
azomethine ylide, and subsequent 1,3-DC reaction with these 
electron deficient alkenes 5 as dipolarophiles, afforded 
biologically active spirooxindolopyrrolizidine derivatives 6 
(Scheme 2).8 
A variant of this green process was the 1,3-DC run with a Morita–
Baylis–Hillman (MBH) adduct 7 (Scheme 2), derived from 
pyridine-4-carboxaldehyde and lauryl acrylate, giving similar 
spirocycloadducts in good yields but employing toluene instead 
of water.9  
 
 
Scheme 2 Green multicomponent synthesis of spirooxindolopyrrolizidines 6. 
 
Potentially bioactive spiroheterocycles 10, containing both 
spirooxindole and pyrrolizidine core structures, were 
enantioselectively prepared by Taghizadeh and co-workers. The 
1,3-DC was carried out in the presence of Cu(OTf)2· 
bis(arylmethyleneamine) 9 chiral complex, ethanol, proline 1, 




Scheme 3 Enantioselective synthesis of spiranic compounds 10. 
 
Highly activated tetraethyl vinylidene-1,2-(bis)phosphonate 11 
was allowed to react with isatins 2 and various amino acids 
(proline 1, sarcosine 13, or piperidine-2-carboxylic acid 14) in 
the presence of montmorillonite as catalyst. The 1,3-DC occurred 
in refluxing acetonitrile obtaining spirotetracyclic adducts 12 as 




Scheme 4 Preparation of spirooxindoles 12 bearing geminal bisphosphonate 
unit.  
 
Alkylidene oxazolones 15 were selected as dipolarophiles to 
synthesize biologically important spirooxindole frameworks 16.  
Diverse isatins 2 and a variety of amino acids such as glycine 17, 
sarcosine 13, L-proline 1, or thiazolidine-4-carboxylic acid 18, 
afforded, in a one-pot tricomponent process, regio- and 
diastereoselective 1,3-DCs (Scheme 5). Biological evaluation of 
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compounds 16 against several cancer cell-lines revealed that 
some of them possessed antitumor activity.12 
 
 
Scheme 5 Synthesis of spirooxindoles 16. 
 
A range of potentially bioactive substituted dispiro-
pyrrolidines/-imidazolidines 23 were prepared in the presence 
of copper(I) thiophene-2-carboxylate (CuTC) catalyst in refluxing 
1,2-dichloroethane (1,2-DCE). Here, the in situ generated imine 
III reacted with the copper(I)-carbene (obtained by 
decomposition of diazocompound 21) giving a fleeting aziridine, 
which evolved thermally to azomethine ylide IV (Scheme 3). The 
reaction proceeded chemo-, regio-, and diastereoselectively in 
very good yields. The complexity of the resulting products 23 is 
obvious because two of the four generated stereogenic centers 
are quaternary carbons (Scheme 6).13  
 
 
Scheme 6 Synthesis of dispiranic compounds 23. 
 
Spirooxindolepyrrolidines 25 (n = 1) and an example of 
spirooxindolepiperidine 25 (n = 2) fused to nitrochromanes were 
prepared from isatin 2 and proline 1 or pipecolic acid 14 as 
azomethine ylide sources. The 1,3-DC occurred in  refluxing 
ethanol (Scheme 7), and proceeded with total control of the 
diastereoselectivity. 14  
A similar cycloaddition with electrophilic alkenes 26, instead of 
using nitroalkene 24, was performed. The cycloaddition 
proceeded chemo-, stereo- and regioselectively throughout the 
styrene moiety. 15 In other contribution, (2-nitrovinyl)imidazoles 
27 (Scheme 7) were allowed to react under similar reaction 
conditions producing a 95:5 ratio of the corresponding 
spirocycloadducts.16 
Trihalomethyl-substituted nitroethylenes 28 (Scheme 7) were 
selected as dipolarophiles to prepare a variety of biologically 
active spirooxoindolepyrrolidines, which may be of interest for 
medicinal chemistry.17 
Analogously, new designed glycol-3-nitrochromenes 29 and 30 
(Scherme 7), derived from glyco-β-nitroalkenes and 
salicylaldehyde, were tested as dipolarophiles in refluxing 
acetonitrile to give the corresponding biologically active sugar-




Scheme 7 Synthesis of spirocompounds 25. 
 
Spirooxindoles 32, bearing quinoline, pyrrolidine, 
pyrrolothiazole and  indolizine ring system hetereocycles, were 
prepared by Kumar et al. from, sarcosine 13, isatin 2 and 
potential bioactive dipolarophiles 31, derived from pyrazolo[3,4-
b]quinolone,  such as it is shown in Scheme 8. The ecofriendly 
reaction was achieved via in situ generated azomethine ylide and 
stereoselective 1,3-DC in a three-component sequential atom 
economy processes.19 This protocol was extended to another 
components such as, thiazolidine-4-carboxylic acid 18 and 
piperidine-2-carboxylic acid 14, together with 
acenaphthenequinone 33, to access potential bioactive diverse 
spiro-tethered pyrazolo quinoline heterocycles 34-37 (Scheme 
8). 
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Scheme 8 Synthesis of spiroxindoles 32, 34-37, from pyrazolo[3,4-b]quinolone 
31.  
 
From symmetric dipolarophiles 38, sarcosine 13, and isatin 
derivatives 2, a series of dispirooxindoles 39 were obtained in 
high diastereoselections. They showed higher potency, against 
the HeLa (cervical) tumor cell line, than reference cisplatin 
derivatives (Scheme  9).20,21  In addition, it was discovered that 
these molecules exhibited antitumor activity against 
hepatocellular cancer (HEPG2) cell line,22 breast cancer (MCF7, 
T-47D) and colon cancer (HCT116).23 
 
 
Scheme 9 Generation of dispiroxindoles 39. 
 
Synthesis of sugar-containing spirocyclic pyrrolidine derivatives 
41 were reported by Raghunathan et al. Here, α-aminoacids, 
ketones and electrophilic olefin 40 incorporating a sugar moiety 
were allowed to react via 1,3-DC (Scheme 10). Proline 1, 
sarcosine 13, tetrahydroisoquinolinic acid 42 or pipecolinic acid 
14 and acenaphthoquinone 33, isatin 2, or indenoquinoxalinone 
43 were employed in this cascade protocol to access a variety of 
biologically important spiroheterocyclic compounds 41 as single 
diastereoisomers.24 Regio- and  diastereo-selective 1,3-DC also 
afforded dispirooxindolopyrrolidines in a similar way, but 
employing  3-arylmethylidene-5-phenyl-3Н-furan-2-ones 44,25 
or 3,5-diarylmethylenespiro[indole-30,2- [1,3]thiazolane]-
20(1H)-4-diones 45 as dipolarophiles (Scheme 10).26 
 
 
Scheme 10 Synthesis of sugar-containing spirocyclicpyrrolidines 41.  
 
Another potential bioactive dispirooxindolo derivatives 48 were 
described by Mondal and co-workers from N-benzyl glycine 46 
and isatins 2 or acenaphthoquinone 33 with andrographolide 47, 
isolated from A. paniculata, as dipolarophile (Scheme 11). Their 
cytotoxic potential and antitimural activity of these 
spiroheterocycles 48 displayed more potency against MCF-7 
breast cancer cell line when comparing andrographolide 47 
itself.27  
This promising activity, confirmed by biological tests, moved to 
the authors to elaborate new semisynthetic antitumor 
spirooxindole frameworks from acenaphthoquinone 33 (or 
isatin 2 derivatives) and secondary amino acids such as sarcosine 
13, and proline 1.28 
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Scheme 11 Synthesis of dispiroandrographolide-type cycloadducts 48 via 1,3-
DC of azomethine  ylides. 
 
Dispiroxindole heterocycles 50, possessing dihydroanthracene 
ring system, were diastereoselectively prepared by Arumugam  
et al. in the presence of an ionic liquid (1-butyl-3-
methylimidazolium bromide [bmim]Br), isatin 2, sarcosine 13 




Scheme 12 Preparation of dispirooxindoles 50 using an ionic liquids as solvent. 
 
A series of spiroxindolepyrrolidines 53 showing potential 
cholinesterase inhibitory activity were prepared by Kumar et al. 
In ionic liquid medium the 1,3-DCs of the azomethine ylide, 
formed with 1,2-diketones, such as isatins 2 or 
acenaphthenequinone 33, and tryptophan 51, with 
arylmethylidene inden-1-ones 52, were successfully achieved. A 
representative example is shown in Scheme 13.30 Other 
dispirooxindolopyrrolidines were prepared using 1-butyl-3-
methylimidazolium bromide by mixing the corresponding amino 




Scheme 13 Potential cholinesterase inhibitors 53 obtained via 1,3-DC. 
 
Biologically important aryl-/heteroaryl-substituted 
functionalized spiroxindole derivatives 56 were obtained 
employing electrophilic alkenes 55 containing an indole unit. 
Apart from isatins 2 and proline 1, other components such as 
acenaphthoquinone 33 or ninhydrin 57, sarcosine 13 and 
alkenes 58 (bonded to a pyrrole ring) were successfully tested. 
In general, the chemical yields and the diastereoselections were 
very high (Scheme 14).32  
 
 
Scheme 14 Sythesis of biologically important aryl-/heteroaryl-substituted 
cycloadducts 56. 
 
Spiroxindole-fused cycloadducts 60 and 61 were reported by 
Perumal et al. from 1,3-thiazolane-4-carboxylic acid 18 or 
sarcosine 13 and substituted isatins 2 as source of azomethine 
ylide intermediates. The 1,3-DC with 
benzimidazolphenylacrylonitrile 59 as dipolarophile occurred, in 
refluxing methanol, in very high yields and excellent 
diastereoselections (Scheme 15). This protocol, operating in a 
one-pot three-component manner,33 was employed in the 
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reactions involving nitrile 62 (Scheme 15). The combination of 
62 with isatin derivatives 2 and with the corresponding α-amino 
acid (1, 13, or 18) furnished biologically important cycloadducts 
with very interesting activities against bacteria and fungi.34 
 
 
Scheme 15 Synthesis of spiroxindole-fused heterocycles 60 and 61.  
 
Preparation of dispiro-acenaphthylen-2-one curcuminoids 64 
and 65 were described by Mondal et al. from acenaphthoquinone 
33 and proline 1 as precursors of the corresponding azomethine 
ylide, together with curcumin 63 as dipolarophile. This attractive 
natural compound allowed the preparation of spirocycloadducts 




Scheme 16 Synthesis of dispiro-oxindole analogues 64 and 65 from curcumin 
63. 
 
Synthesis of spirooxindolepyrrolizines 69, bearing a 1,2,3-
triazole moiety, was reported by Khurana et al. via stereo- and 
regioselective 1,3-DC. The in situ generated azomethine ylide V in 
glacial acetic acid triggered this one-pot four component domino 
strategy (Scheme 17). This cascade reaction involved the 
formation of the triazole derived from N-propargylated isatin 67 
and aryl azides 66 in the presence of copper(II) sulfate. Then, the 
reaction with L-proline 1 or sarcosine 13 and decarboxylation  of 
the resulting intermediate afforded the corresponding 
azomethine ylide V, which reacted with coumarin-3-carboxylic 
acid 68 as dipolorophile giving the desired spirooxindoles 69 in 
very good yields (Scheme 17).36 
 
 
Scheme 17 Synthesis of spirooxindolepyrrolizines fused to coumarin ring 
heterocycles 69. 
 
Dispirooxindolepyrrolidines 71 were reported by Singh et al. and 
prepared from sarcosine 13, isatins 2 with N-aryl-3-benzylidene-
pyrrolidine-2,5-diones 70 as dipolarophiles. These products 
were diastereoselectively isolated in high yields (Scheme 18).37 
Glycine 17 or sarcosine 13 with isatins 2,38 or even proline 1 plus 
acenaphthenequinone 33 or indenoquinoxaline-11-one 43 were 
also essayed in the presence of dipolarophiles 70.39 
 
 
Scheme 18 Substituted spiroxindoles 71 obtained via 1.3-DC of azomethine 
ylides. 
 
Spiro-pyrrolizidinooxindoles 73 and 74, derived from isatins 2 
or acenaphthoquinone 33, respectively, bearing a withaferin-A 
system were isolated by Mondal and co-workers. Proline 1 was 
selected as precursor of the azomethine ylide, which furnished 
exclusively cis-fused cycloaducts 73 and 74 in a total atom-
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economic one-pot three-component manner (Scheme 19). Their 
bioactivities were evaluated exhibiting a very promising 
cytotoxicity towards various cancer cell lines.40 
 
 
Scheme 19 Spiropyrrolizidino polycycles bearing withaferin-A sterodial ring 
system 73 and 74. 
 
Substituted spirooxindolepyrrolizines 77 (X = CH2), and spiro-
oxindolethiazoles 77 (X = S) were prepared from a range of 
secondary α-amino acids (proline 1 or 1,3-thiazolane-4-
carboxylic acid 18)  and dialkyl acetylenedicarboxylates 75 as 
precursors of azomethine ylides VI. Interestingly, this way of 
generating in situ azomethine ylides reacted with substituted 
methyleneoxindoles 76 through a sequential 1,3-DC (Scheme 
20).  This reaction protocol was also extended to the use of 
another α-amino acid derivatives to yield the corresponding 
spiroheterocycles under thermal conditions.41  
 
 
Scheme 20 Synthesis of spirooxindolepyrrolizines 77 (X = CH2), and 
spirooxindolethiazoles 77 (X = S) from dialkyl acetylenedicarboxylates. 
 
The unprecedented formation of dispirooxindolepyrrolizine 
thiazolidine-2,4-diones 79, contrary to the commonly observed 
regiochemistry, was described by Kumar et al. via one pot three-
component 1,3-DC from isatin 2, proline 1 and (Z)-arylidene 
thiazolidine-2,4-diones 78. The reaction took place under 
refluxing methanol with total regio- and diastereoselection 
(Scheme 21).42 Many biological studies concerning medical 
applications of heterocycles 79 are currently in progress. 
 
 
Scheme 21 Synthesis of spirocycles 79 with reverse regiochemistry.  
 
Dandia and co-workers constructed diastereoselectively various 
biologically important dispiropyrrolidinethiapyrrolizidine 
frameworks 81. Trifluoroethanol (TFE) was employed as 
enviromentally friendly solvent and also as catalyst due to its 
Bronsted acidity. Isatin derivatives 2 or azanaphthoquinone 80 
(X = NH), benzooxazinone 80 (X = O) derived electrophilic 
alkenes and sarcosine 13 or 1,3-thiazolidine carboxylic acid 18 
were the components used in this study (Scheme 22).43 
 
 
Scheme 22 Preparation of novel dispiroheterocyclic hybrids 81. 
 
Bisspirooxindolopyrrolidines 83 and bisspirooxindolo-
pyrrolizidines 84 were reported by Javidan et al. employing 
bischalcone 82 as bisdipolarophile in the 1,3-DC involving isatins 
2 and secondary α-amino acid derivatives such as proline 1 or 
sarcosine 15.  Final cycloadducts were obtained under mild 
conditions in very high both chemical yields and 
diastereoselections (Scheme 23).44 The biological activity of 
selected molecules 83 or 84 are under study. 
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Scheme 23 Bisspirooxindole ring systems 83 and 84 obtained via 1,3-DC of 
azomethine ylides. 
 
Biologically active quinolines containing both indoline and 
spirooxindole core structures 86 were designed by Mohan and 
co-workers. The 1,3-DC was carried out from sarcosine 
13/thiazolydine-4-carboxylic acid 18 together with isatins 
2/acenaphthoquinone 33/ninhydrin 57 and with designed (E)-
3-[(quinolin-3-yl)methylene]indolin-2-one derivatives 85 as 
dipolarophiles (Scheme 24). Biological evaluation of this new 
spiroheterocycles 86 revealed important in vitro antioxidant, 




Scheme 24 Synthesis of spirocyclicquinolines 86. 
 
Bioactive spirooxindoles 88, incorporating a steroidal 
framework, were reported.  Isatin 2 and sarcosine 13 reacted 
with a newly designed steroidal dipolarophile 87, derived from 
pregnenolone, through a conventional 1,3-DC under mild 
reaction conditions (Scheme 25). The produced 
spirooxindolepyrrolidines 88 exhibited antiproliferative 
activities against four human cancer cell lines including MCF-7.46 
 
 
Scheme 25 Synthesis of new steroidal spirooxindole frameworks 88. 
 
Interesting bioactive chiral enantioenriched spiroxindole 
derivatives 92 were prepared in the presence of a chiral ligand 
91 (35 mol%) from  isatins 2, diethyl 2-aminomalonate 89 and 
aldimine 90. This three-component reaction occurred via 
asymmetric 1,3-DC between the imine 90 and the azomethine 
ylide. The resulting structurally congested imidazolidines 92 
were isolated with good chemo-, diastereo- and 
enantioselections (Scheme 26).47 
 
 
Scheme 26 Synthesis of enantiomerically enriched spiroxindole derivatives 92.  
 
Synthesis of pentacyclic spirooxindole pyrrolidines 96 were 
prepared from the in situ generated tricyclic azomethine ylide 
derived from pyridone-annelated isatin 95 and amino acids 93 
and maleimides 94 in refluxing aqueous methanol (Scheme 27).48 
It is noteworthy the preference of the attack of amino group of 
the acids 96 towards the hydrate moiety, rather than the 
conjugated alkene moiety present in the two components 94 and 
95 involving in the cycloaddition. 
 
 
Scheme 27 Synthesis of pentacyclic spirooxindolepyrrolidines 96. 
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Dipolarophiles 97 were employed in the enantioselective 1,3-DC 
catalyzed by chiral bisphosphoric acid 98. The enantiomerically 
enriched bis-spirooxindolepyrrolidines 99 were obtained in 
good yields, very high diastereomeric ratios and excellent 
enantioselectivities in ethanol at 50 °C. Isatins 2 and 
diethylaminomalonate 89 were also the precursors of the 
azomethine ylides (Scheme 28).49 
 
 
Scheme 28 Enantioselective synthesis of spirocycles 99. 
 
Biologically important substituted spirooxindole cycloadducts 
101 were obtained by Shi and co-workers in the presence of the 
same chiral bisphosphoric acid 98 as organocatalyst. This 
enantioselective 1,3-DC with isatins 2, diethyl aminomalonate 89 
and alkyl 2,3-allenoates 100 as dipolarophiles, furnished 
enantioenriched anticancer and antimicrobial spiro[indoline-
3,2′-pyrrole] frameworks 101 in high diastereomeric ratios and 
good to excellent enantioselections (Scheme 29).50  
 
 
Scheme 29 Synthesis of enantiomerically enriched spirocycles 101. 
 
Dialkyl but-2-ynedioates 75 acted as dipolarophiles during the 
multicomponent 1,3-DC with cyclic α-amino acids such as proline 
1, 4-thiaproline 18, or (2S,4R)-4-hydroxyproline 102, with 
isatins 2. The resulting spirooxindolepyrrolizines 103 were 
isolated in good yields (Scheme 30). In addition, 
spiroxindoleazepines 104 were isolated as major compounds 
when two equivalents of electrophilic alkyne 75 were added 
together with one equiv of the rest of components. In this last 








3. Synthesis of spiropyrrolidines 
 
Non-asymmetric synthesis of diazaspiropyrrolidine  derivatives 
106, possessing a dihydroisoquinoline moiety, were prepared 
from isoquinolines 105 with 3 equiv of the corresponding 
maleimide 94 without solvent at 70 ºC. The intermediate 
azomethine ylide VII was not formed as usual but through a 
Michael-type addition of the isoquinoline onto malimide followed 
by a prototropic shift (Scheme 31).52 
 
 
Scheme 31 Synthesis of diazaspiropyrrolidines 106. 
 
Spiroheterocycles 109, containing both pyrrolidine and 
indanone core structures, were synthesized from iminoesters 
107 and alkylidene-1-indanone derivatives 108 as dipolarohiles 
in the presence of a series of imidazolium salts as catalysts. The 
diastereoselectivities were low but the chemical yields were 
excellent under mild conditions. The catalyst was efficiently 
recovered and reused several times without losing efficiency 
(Scheme 32).53 
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Scheme 32 Synthesis of prolinates 109. 
 
A pyrrolidine ring bearing two quaternary centers corresponding 
to spiranic systems 113 was also designed for the construction of 
natural alkaloids. Liu et al. reported a one pot five-component 
reaction to produce dispiroindenoquinoxalinepyrrolidines 113 
from 1,3-indanedione 111, 1,2-phenylenediamine 110, 
ninhydrin 57, sarcosine 13, and aromatic aldehydes (for example 
112). A plausible mechanism proposed by the authors suggested 
that the formation of indenoquinoxaline-11-one 43, from 
condensation reaction of 1,2-phenylenediamine 110 and 
ninhydrin 57, and subsequent reaction with sarcosine 13 and 
decarboxylation afforded the corresponding azomethine ylide. 
Then, stereoselective 1,3-DC with the dipolarophile 114 (derived 
from the aldehyde 112 and 111) produced the desired 
dispiroindenoquinoxalinepyrrolidines 113  (Scheme 33).54 Some 
spiropyrrolothiazoles were prepared using a similar strategy but 
employing different components as (E)-β-nitrostyrene,55 or even 
1,3-thiazolane-4-carboxylic acid as dipolarophiles. 56 
 
 
Scheme 33 Synthesis of dispiroindenoquinoxalinepyrrolidines 113 in a one-pot 
five-component process. 
 
Novel steroid grafted dispiroindenoquinoxalinepyrrolidines 117 
were prepared by Raghunathan et al. from ninhydrin 57, 
sarcosine 13, 1,2-phenylenediammine 110 and estrone derived 
dipolarophiles 115 in the presence of an ammonium salt 116 as 
catalyst. This facile one-pot four-component [3+2]-cycloaddition 
occurred under mild reaction conditions, easy workup, and in 
good yields (scheme 34).57 This method is valuable for the 
synthesis of steroidal surrogates of biological significance. 
 
 
Scheme 34 Preparation of steroidal alkaloids 117. 
 
Enantioselective 1,3-DC between imino esters 107 and α-
alkylidene succinimides 70 were successfully achieved 
employing Cu(OAc)2 and N,O-chiral ligand 118. Structurally 
diverse functionalized endo-dispiropyrrolidine cycloadducts 119 
were obtained in very high diastereoselection and high to 
excellent enantioselections (up to 97% ee) (Scheme 35). These 
cycloadducts were transformed into N-
methylbispiropyrrolidines and further reduction with LiAlH4 
afforded functionalized substituted spiroheterocycles 120 in 
good yield and up to 99% ee. This process was also applied to 
enantioselective 1,3-DC with 2-oxoindolin-3-ylidenes 121 as 
dipolarophiles giving biologically active exo-dispiropyrrolidine 
skeletons 122 in good yield and up to 95% ee (Scheme 35). 58 
 
Synthesis Review / Short Review 
Template for SYNTHESIS © Thieme  Stuttgart · New York 2017-07-11 page 11 of 30 
 
Scheme 35 Enantioselective 1,3-DC of spiranic systems by intermediacy of 
Cu(OAc)2·118. 
 
Synthesis of enantiomerically enriched diaza-
bisspiropyrrolidines 125 and 126 was reported by Cossío and 
co-workers. Initially an interrupted 1,3-DC was performed in the 
presence of the catalytic complex Cu(MeCN)4PF6·127 with the 
aim of obtaining the cis- or the trans- γ-lactams 123, respectively. 
The diastereoselective 1,3-DC was performed with these imines 
and nitroalkenes, vinylic sulfones, acrylates, etc., using 
stoichiometric amounts of AgOAc (Scheme 36).59 At this moment, 
this family of spiranic compounds are being evaluating as 
anticancer agents.  
 
 
Scheme 36 Synthesis of spirocycles 125 and 126. 
 
A range of chiral highly substituted spironitroprolinates 131 
were reported in the presence of chiral bifunctional catalytic 
ligand based on [(R,R)-Me-DuPhos] 130 and AgF as source of 
chiral induction. The 1,3-DC was run with α-imino-γ-lactones  
128 and nitroalkenes 129 as dipolarophiles.60 The reaction 
proceeded enantio- and diastereoselectively to form up to four 
new chiral centers and overwhelmingly endo-spiranic 
cycloadducts 131 (Scheme 37).61 Biological  evaluation of some 
of these compounds revealed promising antitumor activity. 
 
 
Scheme 37 Synthesis of enantiomerically enriched spironitrocompounds 131. 
 
Asymmetric synthesis of biologically important tricyclic 
spiroheterocycles endo-134 possessing a cyclopropane unit was 
described. α-Imino-γ-lactones 128 reacted with 
cyclopropylidene acetates 132 as dipolarophiles using CuBF4·TF‐
BiphamPhos 133 as catalyst to afford endo-spirocycloadducts 
134 in good diastereoselectivities and very high 
enantioselectivities (Scheme 38).62  
 
 




4. Synthesis of spiropiperidines and piperidines  
 
The   2,3-pyrrolidino-3,4-piperidine   (4,7-diazabicyclo-
[4.3.0]nonane) scaffold is an integral part of the underlying 
structure  of  numerous  alkaloids  possessing diverse 
bioactivities, including anti-tumor, antibiotic, and insecticidal 
activity. 
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Biologically active spiropiperidine derivatives 136 were 
reported by Guo and co-workers starting from homoserine 
lactone 128 and tropone 135 as dipolarophile. Here, a [6+3] 
cascade cycloaddition took place in the presence of AgOAc·PPh3 
as catalyst and DBU as base. The final diastereoselectivity was 




Scheme 39 Preparation of heterocycles 136 
 
Potentially bioactive functionalized enantioenriched bridged 
piperidine derivatives 139 were designed by Wang et al. in the 
presence of Cu(MeCN)4BF4·138 catalytic system. The [3+6] 
cycloaddition with acyl heptatrienes 137 produced the 
corresponding exo-cycloadducts 139 with multiplication of 
stereocenters with excellent exo-selectivity in good yields and up 
to 99% ee (Scheme 40).64   
 
 
Scheme 40 Enantiomerically enriched exo-cycloadducts 139.  
 
A range of important substituted enantiomerically enriched 
pyrrolidinopiperidine derivatives 142 were synthesized by 
Waldmann and co-workers. The intramolecular 1,3-DC reaction 
of starting iminoamides 140 (generated from the corresponding 
N-Boc protected amine) occurred in the presence of the chiral 
complex formed by Cu(MeCN)4BF4 and chiral ligand 141. Final 
fused bicycle 142 was obtained in good yields, excellent 
diastereoselections and very high diastereomeric ratio (Scheme 
41).65 Once product 142 was formed, a sequential addition of (E)-
cinnamaldehyde 143 and alkenes 124 took place yielding fully 
substituted fussed-pyrrolizidines 144 in good conversions 
(Scheme 41). The main interest of this work was the definition of 
the scaffolds of glycosidase inhibitors, which have been the 
subject of numerous investigations. 
 
 
Scheme 41 Enantioselective synthesis of cycloadducts 142 and 144. 
 
The elaboration of biologically important substituted tetrahydro-
γ-carbolines 147 was performed during the enantioselective 
[3+3] cycloaddition between imino esters 107 and 2-
indolylnitroethylenes 145 in the presence of CuPF6·Ph-
Phosferrox 146 as catalytic complex. This chemo- and 
stereoselective [3+3] cycloaddition was produced, rather than 
expected 1,3-DC, in very high yields, diastereomeric ratios and 
enantioselectivities (Scheme 42).66 The proposed stepwise 
mechanism, caused by the high stability of the resulting enolate 
of the Michael-type addition, favored the Friedel-Crafts reaction 
of the nucleophilic 3-position of the indole. 
 
 
Scheme 42 Synthesis of tetrahydro-γ-carbolines 147 via [3+3] cycloaddition. 
 
 
5. Synthesis of pyrrolidines and fused pyrrolidines 
 
Pyrrolidine ring systems possessing a chiral sugar building block 
149 were reported by Thangamuthu et al. from sarcosine 13, 
paraformaldehyde and an electrophilic alkene bonded to a full-
protected glucopyranosyl unit 148. The cycloadduct was isolated 
in good yield and as only one diastereoisomer (Scheme 43).67 The 
biological evaluation of these compounds are currently in 
progress, demonstrating very promising applications.  
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Scheme 43 Diasteroselective synthesis of sugar derivatives 149. 
 
With the same aim, new pyrrolidine-containing macrocycles 151, 
bearing a triazole ring and a sugar (D-glucose) fragment, were 
prepared via intramolecular 1,3-DC of azomethine ylide.68  The 
1,3-DC occurred diastereoselectively in refluxing toluene in good 
yields independently of the amino acid employed (scheme 44). 
This  strategy  provides  opportunities  for  the preparation  of  
libraries of carbohydrate  grafted  macrocycles  with triazole 
spacer unit for biological screening.  
 
 
Scheme 44 Synthesis of biologically important macrocycles 151. 
 
A series of polyhydroxyalkylpyrrolidines 153 and ent-153, as 
potential inhibitors of a β-galactofuranosidase, were described 
by Varela et al. employing a silver-catalyzed 1,3-DC from imino 
esters and (S)- or (R)-sugar  pyranone as dipolarophiles (Scheme 
45).69 After a sequence of reactions comprised by hydrolysis, 
reductions, N-protection, degradative oxidations, etc., allowed 
the access to polyhydroxyalkylpyrrolidines 154-156, which 




Scheme 45 Synthesis of polyhydroxyalkylpyrrolidines 153 and ent-153 and 
heterocycles 154-156 via 1,3-DC of azomethine ylides. 
 
Recently, an approach to the synthesis of parkacine 159 (a 
lycorine-type alkaloid) was communicated. The key step of the 
synthesis consisted in an intramolecular 1,3-DC. Chiral hept-6-
yne-al derivative 157 was selected to construct the C/D ring 
system of a lycorine-type alkaloid parkacine. However, the 
cycloaddition furnished a C/D ring-closure product with opposite 
configurations at 7- and 7a-carbons, after comparison with the 
absolute configuration of the natural product (Scheme 46).70 A 
possible reason of this epimerization could be caused through 
imine–enamine tautomerization (previous to the formation of 
the 1,3-dipole IV) involving the stereogenic center bearing the 
phenyl group.  
 
 
Scheme 46 New approach to the synthesis of parkacine epimer 158 using an 
intramolecular 1,3-DC as key step. 
 
A series of functionalized β-proline dimers, trimers, etc. (eg 162 
and 163), were designed from the corresponding menthyl 
acrylate 160 and iminoglycinate 107 through a silver-catalyzed 
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1,3-DC. The repeating acylation with acryloyl chloride, followed 
by cyclization, allowed the extension of this process towards 
hexamer chiral β-peptide molecular framework 163 in good 
yields (Scheme 47).71 These new poly-β-prolines were generated 
in the two enantiomeric forms exhibiting an important antitumor 
activity in HRPC cells.72 
 
 
Scheme 47 Synthesis of functionalized β-proline dimers and oligomers 162 and 
163. 
 
Concerning non-asymmetric approaches, substituted 
pyrano[2,3-c]pyrrolidines were reported by Sosnovskikh and co-
workers from sarcosine 13, formaldehyde and 4-aryl-6-
(trifluoromethyl)-2-pyrones 164 as dipolarophiles. The 1,3-DC 
produced cis-fused ring cycloadducts with high 
diastereoselectivity in refluxing benzene (scheme 48).73 Several 
applications of these compounds in medicinal chemistry are 
being envisaged.  
Analogously, the synthesis of benzopyrano[3,4-c]pyrrolidines 
was described in a diastereoselective 1,3-DC between an ∝-
iminoester 107 and coumarin in the presence of AgTFA.74 
 
 
Scheme 48 Synthesis of heterocycles 165. 
 
Hydroxypiperidones are important structures since the 
pharmaceutical point of view. They were prepared taking 
advantage of the use of aldehydes as dipolarophiles such as 
occurred in the 1,3-DC involving sarcosine 13, formaldehyde and 
an aromatic aldehyde or ketone 166. Ketal hydrolysis and 
lactonization from 167 afforded isolable compounds 168, which 
can be transformed into the corresponding substituted benzo-
fused pyperidones 169 (Scheme 49).75 
   
 
Scheme 49 Synthetic route to access products 169.  
 
Potential biologically active  benzoxazine framework alkaloids 
173 were obtained through a [3+3] process rather than the 
expected 1,3-DC. Racemic binol-derived phosphoric acid 172 
acted as Brønsted acid catalyst activating the enone dipolarophile 
(Scheme 50).76 A modification of this procedure using GaBr3 
instead of the phosphoric acid furnished cycloadducts in better 
yields and better periselectivities.77 
 
 
Scheme 50 Synthesis of heterocycles 173. 
 
A diversity oriented synthesis (DOS) was described during the 
study of one-pot multicomponent cycloadditions of non-
stabilized azomethine ylides (formaldehyde and N-alkylamino 
acids) and 1,2-diaza-1,3-dienes 174 and 176 as dipolarophiles in 
toluene. It was found that the nature of the substituents in the 
azadiene was crucial for the cycloaddition in such a way that the 
presence of an electron-withdrawing group bound to the azo 
group favored the generation of 1,2,4-triazepines 177 through a 
[4+3] cycloaddition. However, a phenyl group bonded to this azo 
moiety furnished pyrrolidines 175 in a typical 1,3-DC in 
moderate to good yields (Scheme 51).78 
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Scheme 51 Synthesis of pyrrolidines 175 or 1,2,4-triazepines 177 via 1,3-DC or 
[3+4]  cycloaddition of azomethine ylides, respectively. 
 
AgOAc-catalyzed [3+2] cycloaddition of the azomethine ylides 
derived from imino esters 107 and alkenes 178 was successfully 
achieved. Final pyrrolidines 179 were generated in good yields 
and high diastereomeric ratios under mild conditions (Scheme 




Scheme 52 Synthesis of pyrrolidines 179. 
 
The 1,3-DC has been considered the key step in the new approach 
to the synthesis of  fused benzodiazepines 182. This attractive 
family of compounds are under screening. Firstly, the thermal 
multicomponent 1,3-DC took place in the presence of alanine 
derivative 180, 2-azidebenzaldehyde 66, and maleimides 94 in 
short reaction times (Scheme 53).  Triazolobenzodiazepine 
derivatives 182, obtained as unique diastereoisomers, were 
prepared from 181 through conventional N-propargylation 
followed by intramolecular copper-free 1,3-DC of the azido group 
with the alkyne residue.79 
 
 
Scheme 53 Stereoselective synthesis of triazolobenzodiazepines 182. 
 
Unstabilized azomethine ylides, generated from sarcosine 13 and 
paraformaldehyde, reacted with dihetaryl system 183 to give 
several cycloaddition adducts depending of the solvent involved. 
Thus, when benzene was employed product 184 was exclusively 
formed in quantitative yield. However, in the case of using MeCN, 
hydropyrrole 185 and pyrrole 186 were obtained as mixture of 
products in low yields (Scheme 54).80 
 
 
Scheme 54 Sythesis of substituted complex heterocycles 184-186. 
 
A series of substituted N-arylpyrrolidines 188, using various 
electron-deficient alkenes 124 as dipolarophiles during the 
reaction of imino esters 107 to aryne precursors 187, were 
generated in good chemical yields and very high 
diastereoselectivities. Here, the direct attack of the imino esters 
to the aryne and protonation of the resulting anion occurred 
giving raise azomethine ylides VIII and VIII’. In addition, 
imidazolidines 189 were analogously obtained adding 2 equiv of 
imino ester 107 under mild conditions (Scheme 55).81  Both types 
of heterocycles were tested as antiviral agents, specifically to 
those emerging viral infections. 
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Scheme 55 Preparation of imidazolidines 189 and substituted pyrrolidines 188 
from imines 107 and trimethylsilyl aryl triflates 187. 
 
An approach to the synthesis of 6-5-7 ACD azatricyclic ring 
system of numerous calyciphylline A-type alkaloids was 
successfully developed combining reagents 190 and 191. The 
use of H3PO4 as promoter in a highly donating solvent such as 
DMF produced the expected [3+2] cycloaddition under very mild 
conditions. The intramolecular 1,3-DC between a nonstabilized 
azomethine ylide IX→IX’, generated by desilylation of N-
(trimethylsilyl)methyliminium salt, and an electron-poor alkene 
afforded calyciphylline derivative 192 as unique 
diastereoisomer (Scheme 56).82 
 
 
Scheme 56 Intramolecular 1,3-DC reaction to yield calyciphylline type alkaloid 
192. 
 
Bioactive compounds bearing the chromene[4,3-b]pyrrolidine 
moiety 195 were constructed by intramolecular 1,3-DC. α-Amino 
esters 194 and O-crotonylsalicylaldehyde 193 under MW or 
conventional heating afforded alkaloid chromane hetereocycles 
195 in good yields via imine/[1,2]-prototropic shift route 
(Scheme 57). The 1,3-DC was diastereoselective in most of cases, 
obtaining other diastereoisomers in variable proportions.83  
Similar transformations were reported by Nelson and co-
workers in the search of new scaffolds for exploitation in the 
production of alkaloid-like libraries.84 In addition, the 
intramolecular 1,3-DC of allylic aminopyrimidine derivatives was 
also successful and afforded pyrimidine fused tricyclic systems 
196 in very high yields under thermal conditions.85 As an 
extension of this work, the synthesis of potential bioactive 
functionalized fused penta/hexacyclic alkaloids were 
constructed by the substitution of acyclic amino esters by 
tetrahydroisoquinolines (Scheme 57).86 
 
 
Scheme 57 Synthesis of chromanepyrrolidines 195 and 196. 
 
Functionalized aziridines 197 were employed as generators of 
azomethine ylides X by thermolysis in the 1,3-DC with allenes 
198 bearing a tetrazol moiety. The resulting tetrazolyl-
substituted pyrroles 199 or alkylidenepyrrolidines 200 resulted 
to be very attractive since the pharmaceutic point of view. The 
nature of the substituent at the terminal position of the allene 
affected the reaction course when a benzoyl group is bonded to 
the aziridine ring. However, the presence of an ester group 
instead (for example in aziridine 197 X = OEt) was not so 
important producing exclusively pyrrolidines 201 in excellent 
diasteromeric ratios and high chemical yields (Scheme 58).87 
 
 
Scheme 58 DOS of pyrroles 198 and pyrrolidines 199 and 201. 
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Important chromenopyrrole derivatives 203 and 205, were 
prepared by the generation of azomethine ylides from aziridines 
202 and 204 bearing terminal alkyne/allene groups, 
respectively.  The stereoselective intramolecular 1,3-DC took 
place in refluxing toluene giving only one stereoisomer in good 
chemical yields. The triple carbon–carbon bond led the  
corresponding  1,4-dihydrochromeno[4,3-b]pyrrol 203, whilst 
allene allowed the stereoselective  synthesis  of  3-
methylenechromano[4,3-b]pyrrole  derivative 205 (Scheme 
59).88 An alternative way to obtain the fused pyrrole heterocycle 
in good yields, consisted in a sequential one-pot 1,3-DC 
employing synthesis from N-substituted-Boc-glycine-O-aryl 




Scheme 59   Synthesis of chromeno[4,3-b]pyrrole derivatives 203 and 205. 
 
ABC Tricyclic ring system similar to that found in manzamine 
alkaloid framework was prepared by Coldham et al., 1,3-DC being 
one of the three key steps of the synthesis. The 1,3-DC was 
successful with only one diastereomer of 206 demonstrating the 
high control of the geometry of the transition state. The same 
aldehyde was able to afford stereodivergent products 208 or 
206, in moderate to good yields, depending on the reagents 
involved in the generation of the azomethine ylide (Scheme 60).90  
  
 
Scheme 60 Selective synthesis of tricycles 208 and 210. 
 
An unprecedented generation of non-stabilized azomethine 
ylides from N-(trimethylsilylmethyl)amides 211 was optimized. 
The activation of the amide was done with triflic anhydride, then, 
partial reduction with 1,1,3,3-tetramethyldisiloxane (TMDS), and 
desilylation with cesium fluoride afforded the final intermediate 
ylide XIII. Operating under mild conditions, the 1,3-DC tolerated 
several sensitive functional groups and provided cycloadducts 
212 in very good yield. The use of various dipolarophiles were 
successful, cis-diastereoselectivity for the substrates bearing an 
electron-withdrawing group being determined (Scheme 61).91 
The sequence formed by and nonstabilized azomethine ylide 
derived from N-substituted glycine and formaldehyde → 
anthraquinone → 1,3-oxazole formation → generation of 
azomethine ylide → 1,3-DC with electrophilic alkenes was also 
developed for the preparation of substituted pyrrolidines.92 
 
 
Scheme 61 1,3-DC reaction of nonstabilized azomethine ylides derived from 
secondary aromatic N-(trimethylsilylmethyl)amides 211. 
 
Potentially bioactive pyrroles 215 bearing a phosphonate unit at 
the 2-position are currently under evaluation. The preparation 
consisted in a simple 1,3-DC  between imino phosphonates 213 
and 1,3-DC with ynones 214 giving intermediate cycloadducts, 
which underwent a subsequent aromatization (Scheme 62). The 




Scheme 62 Synthesis of pyrroles 215. 
 
The stability of the pyrrol unit was the driving force to construct 
a novel nitrogen-doped corannulene derivative 219. The key 1,3-
dipolar cycloaddition of a polycyclic aromatic azomethine ylide 
precursor 217 with a diarylethyne 216 gave product 218, which 
underwent a palladium-catalyzed intramolecular cyclization to 
complete the synthesis. This molecule represents the first 
example of a corannulene derivative bearing an internal 
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heteroatom, having particular and exclusive physical and 
biological properties (Scheme 63).94 
 
 
Scheme 63 Synthesis of azacorannulene derivative 219. 
 
Amine 221 has been widely used for the generation of non-
stabilized azomethine ylides under very mild conditions. In other 
side, the reaction of an azomethine ylide with a carbonyl group of 
an anhydride is not common. However, isobenzofuranone 
heterocycles 222 were obtained by the in situ generation of a 
dipole from N-silylatedbenzylamine 221 and phthalic 
anhydrides 220 affording spirooxazolidines 222 in very good 
yields and elevated regiocontrol (Scheme 64).95 
 
 
Scheme 64 Synthesis of isobenzofuranones 222. 
 
Pentafluorosulfanyl (SF5) group is not very common in nature, so 
the biological study of compounds incorporating it is very 
attractive. Bouillon and co-workers published a 1,3-DC between 
N-(methoxymethyl)-N-[(trimethylsilyl)methyl]benzylamine 221 
and SF5-substituted acrylic ester 223 or its corresponding amide 
as dipolarophiles afforded trisubstituted pyrrolidines 224 in 
good yields. In the case of using benzylideneglycine methyl ester 
107, the 1,3-DC was produced in the presence of AgOAc/PPh3 as 
catalyst furnishing almost equimolar mixtures of cycloadducts 
225 and 226 (Scheme 65). 96   
 
 
Scheme 65 Synthesis of heterocycles 224-226 from alkenes 223. 
 
In this context, very interesting imidazolidines 228 were 
obtained during the employment of N-sulfinylketimines 227 as 
dipolarophiles in 1,3-DC with non-stabilized azomethine ylide 
precursor 221. In the presence of substoichiometric amounts of 
diphenyl phosphate the reaction proceeded in good yields and 
high diastereoselections (Scheme 66).97 
An identical mode of generating the azomethine ylide from the N-
(trimethylsilylmethyl)benzylamine 221 derivative was 
employed in the reaction with electrophilic alkenes 
incorporating a trifluoromethyl group, fluorinated acrylates or 3-
fluoromaleimides. The resulting N-benzylpyrrolidines were 
obtained in very high yields.98,99 
 
 
Scheme 66 Synthesis of imidazolidines 228. 
 
The silver-catalyzed multicomponent reaction between ethyl 
glyoxylate, 2,2-dimethoxyacetaldehyde, or phenylglyoxal as 
aldehyde components (in general 229) with α-amino ester 
hydrochlorides 230 and a dipolarophile (for example, 
maleimides 94) in the presence of trimethylamine, was 
described. This domino process took place at room temperature 
by in situ liberation of the α-amino ester followed by the 
formation of the imino ester, which is the precursor of a 
metalloazomethine ylide. The cycloaddition of this species and 
the corresponding dipolarophile afforded polysubstituted 
proline derivatives. Ethyl glyoxylate (229, X = CO2Et) reacted 
with glycinate, alaninate, phenylalaninate and phenylglycinate at 
room temperature in the presence of representative 
dipolarophiles affording endo-2,5-cis-cycloadducts 231 in good 
yields and high diastereoselection. In addition, 2,2-
dimethoxyacetaldehyde [229, X = CH(OMe)2] was evaluated with 
the same amino esters and dipolarophiles, under the same mild 
conditions, generating the corresponding endo-2,5-cis-
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cycloadducts with higher diastereoselections than the obtained 
in the same reactions using ethyl glyoxylate. In the case of 
phenylglyoxal (229, X = Ph) the corresponding 5-benzoyl-endo-
2,5-cis cycloadducts 231 were obtained in short reaction times 
and similar diasteroselections (Scheme 67).100 In these examples, 




Scheme 67 Synthesis of pyrrolidine cycloadducts 231. 
 
The enantioselective version of these transformations was also 
separately reported for reactions run with ethyl glyoxylate and 
2,2-dimethoxyacetaldehyde. Enantiomerically enriched 
substituted fused bicyclic pyrrolidine derivatives (231, X = 
CO2Et) were obtained in a multicomponent 1,3-DC from ethyl 
glyoxylate (229, X = CO2Et) and phenylalanine (230, R1 = Bn) in 
the presence of Ag2CO3·(S)-Binap 233 catalytic complex. 101  
However, Taniaphos 234·silver fluoride complex was the 
appropriate catalyst to produce an enantioselective 1,3-dipolar 
cycloaddition using 2,2-dimethoxyacetaldehyde derived imino 
esters 232 and maleimides 94 (Scheme 68).102 The employment 
of both complexes in their respective transformations allowed 
the reaction in the absence of an extra base giving high yields and 




Scheme 68 Enantioselective synthesis of prolinates 231. 
 
Enantiomerically enriched substituted bicyclic pyrrolidines 
fused to cyclopentanediones 237 were described by Wang et al. 
in the presence of AgOAc and (S)-TF-BiphamPhos 236 as 
catalytic system. The reaction was performed at -20 ºC affording 
products 237 in good yield and high optical purity (up to >99 ee) 
(Scheme 69).103 Bicyclic heterocycles fused by pyrrolidine and 
cyclopentane moieties play a unique role in numerous bioactive 
naturally occurring compounds and pharmaceutical ingredients. 
This chiral catalytic complex was also employed for 
atroposelective desymmetrization of N-(2-t-
butylphenyl)maleimides during the enantioselective 1,3-DC 
affording enantiomerically pure cycloadducts 239, which could 
be transformed into pyrrolines (eg 240) and pyrroles (eg 241) in 
good yields (Scheme 69).104 A similar approach was reported by 
Singh et al. with excellent enantioselections but employing Pri-
Phosferrox 238 (R = Pri).105 
 
 
Scheme 69 Asymmetric synthesis of series of heterocycles 237, and 239-241. 
 
Biologically active isoxazolylpyrrolidines 244 were 
stereodivergently constructed by Wang and co-workers in the 
presence of AgOAc and various chiral ligands. The 1,3-DC with 
imino esters 107, alkene 242, using the catalyst system formed 
with But-Phosferrox 238 (Alkyl = But) gave diastereo- and 
enantioselectively endo-cycloadducts 244 in good yields. In 
contrast, the exo-cycloadducts were formed in the presence of 
chiral phosphoramidite ligand 243 (Scheme 70).106 
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Scheme 70 Modulated synthesis of optically pure endo- and exo-cycloadducts 
244. 
 
Attractive nitroprolinates 247 incorporating a trifluoromethyl 
group were employed in several biological tests. They were 
enantioselectively prepared from imino esters 107 and β-
(trifluoromethyl)nitroalkenes 245 by intermediacy of a chiral 
copper(I)·246 complex under mild conditions. In general 
enantio- and diastereoselections were excellent and chemical 
yields were good (Scheme 71).107 
 
 
Scheme 71 Enantioselective preparation of nitroprolinates 247. 
 
Diamino substituted pyrrolidine derivatives 252 are very 
attractive compounds in many scientific areas. Their synthesis 
was accomplished in a Cu(MeCN)4BF4·chiral bidentate ligand 
249 catalyst system from iminoesters 107 and β-
phthalimidonitroethylene 248. The endo-cycloadducts 251 were 
obtained as unique diastereoisomers and immediately 
underwent reduction with Ni-Raney followed by generation of 
the second free amino group (Scheme 72).108 An analogous 
process, in which a modulation of the ligand was attempted, was 
reported during the enantioselective 1,3-DC of imino esters 107 
and 2-phthalimidoylacrylates 253, mediated by chiral ligand 
250, in very good yields and both excellent diastereo- and 
enantioselectivities.109 In general, prolinates and nitroprolinates 
exhibit many useful properties in sciece. 
 
 
Scheme 72 Synthesis of enantiomerically enriched diamino substituted 
pyrrolidines 253. 
 
These imino esters also were allowed to react with nitrostyrene 
derivatives 129 through an enantioselective 1,3-DC reported by 
Fukuzawa et al.. AgOAc·ThioClickFerrophos (TCF) 254 complex, 
acting in a bifunctional mode, was the best catalyst to yield the 
corresponding endo-cycloadducts  255 (Scheme 73).110,111 
 
 
Scheme 73 Enantioselective synthesis of nitroprolinates 255. 
 
Enantioenriched exo’-pyrroloindolines 258 possesing four 
stereogenic centers were reported in the presence of an in situ 
generated catalyst system obtained from Cu(OTf)2 and (R)-
Difluorphos 257, from alanine imino esters 107 and 3-
nitroindole surrogates 258. The dearomative 1,3-DC occurred in 
high diastereoselections and with notable enantioselectivities 
(Scheme 74).112 These tricyclic entities are present in many 
natural products and is a straightforward and simple manner to 
access them.  
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Scheme 74 Asymmetric synthesis of polycyclic compounds 258. 
 
The synthesis of trifluoromethylated pyrrolidine derivatives 260 
and 262 was reported by Carretero and co-workers. The 
hetereocycles were obtained from a series of trifluoromethyl-
substituted iminoesters 259 or trifluoroethyl imines possessing 
a 2-pyridyl unit 261. The 1,3-DC proceeded in tert-butyl methyl 
ether (TBME) in very good yields and excellent endo-
diastereoselections  with a variety of dipolarophiles 124 in the 
presence of AgOAc/PPh3 and Cs2CO3 as base (Scheme 75).113 The 
enantioselective transformation using the chiral complex formed 
by AgOAc/Taniaphos 234 afforded endo-diastereoselection with 




Scheme 75 Synthesis of trifluoromethylated pyrrolidine derivatives 260, 262 
and 263. 
 
Some fused tricyclic heterocycles 266 were enantioselectively 
constructed by Waldmann and co-workers in the presence of 
Cu(MeCN)4BF4·Fesulphos ligand 265 catalyst.  Iminoesters 107 
(2 equiv), cyclopentadiene 264 and the catalyst, under the 
optimized conditions, developed a multicomponent cascade 
reaction which allows the highly diastereo- and enantioselective 
synthesis of complex natural product cores 266 with eight 
stereocenters in moderate to good yields (Scheme 76).114 A 
notable feature of the process was the aerobic copper-catalyzed 
oxidation of cyclopentadiene to cyclopentadienone previous to 
the 1,3-DC.  
 
 
Scheme 76 Natural product frameworks 266 obtained via double 1,3-DC of 
azomethine ylides. 
 
Carretero and co-workers have designed a very interesting 
stereodivergent methodology based in a 1,3-DC of  azomethine 
ylides and an activated 1,3-diene 268.  The cycloaddition 
occurred selectively at the terminal C=C bond of the diene and, in 
basis of the chiral ligand employed, the diastereoselection can be 
controlled. Thus, DTBM-Segphos 269 and BTFM-Garphos 271 
favored the formation of the exo- and endo-cycloadducts 272, 
respectively, in good yields, high diastereocontrol and excellent 
enantioselectivities (Scheme 77).115 This process had potential 
versatility to access to chromeno[4,3-b]pyrrole structures 273 
and the tetracyclic skeleton core of the alkaloid gracilamine 274. 
The same research group reported a diastereoselective one-pot 
synthesis of hexahydrocyclopenta[b]pyrrole derivatives using a 
similar catalytic system with (E)-tert-butyl 6-bromo-2-
hexenoate and α-imino esters. This enantioselective 1,3-DC was 
followed by an intramolecular alkylation.116 
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Scheme 77 Biologically important substituted pyrrolidines 270 ans 272 and 
alkaloid framework of natural product 274  via enantioselective 1,3-DC of 
azomethine ylides. 
 
Tetrasubstituted endo-pyrrolidines 277 were prepared in the 
presence of a metal catalyzed system (Ag2CO3/chiral amidphos 
ligand 276). Imino esters 107 and dialkyl maleates 275 reacted 
at room temperature in good yields. This multifunctional catalyst 
was able to act in particular reactions with a Brönsted acid 
domain (Scheme 78).117,118 
 
 
Scheme 78 Enantioselective generation of endo-cycloadducts 277. 
 
Chiral C-3 unsubstituted pyrrolidine cycloadducts 279 were  
reported by Vicario and co-workers in the presence of L-proline 
1 as catalyst with the idea of preparing deoxyazasugar 
surrogates. The 1,3-DC was set up from diethyl 
arylideneaminomalonates 171 and with acrolein 278 as 
dipolarophile  affording chiral cycloadducts, which were reduced 
to the corresponding primary alcohols 279 in good yields and 
high diastereo- and enantioselections (Scheme 79).119 
These imino esters 171, derived from aminomalonates, and 
ethynyl ketones were also employed by Deng and co-workers in 
the enantioselective synthesis of chiral functionalised 2,5-
dihydropyrrole framework. In this example, the complex formed 
by Cu(OAc)2·Ph-PhosFerrox 146 was the selected catalyst 
affording cycloadducts in both high diastereoselectivities (98:2–
>99:1) and enantioselectivities (89–92% ee).120  
 
 
Scheme 79 Organocatalyzed 1,3-DC affording adducts 279. 
 
Chiral organocatalysts were also very effective in 
enantioselective 1,3-DC of azomethine ylides generated from 
imino esters 107 and alkenes 137. Bioactive  substituted  
pyrrolidines 281 fused to a cycloheptatriene unit were reported 
by Jørgensen et al. in the presence of  chiral 
cyclopropenediamines 280 as chiral base catalyst. The reaction 
proceeded stereoselectively and produced one diastereoisomer 
in high enantioselections (Scheme 80).121 The transformations 
done in the diene part of cycloadduct gave access to new 
potentially bioactive heterocycles. 
 
 
Scheme 80 Synthesis of substituted pyrrolidines 281 fused to a 
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6. Synthesis of pyrrolizidines and indolizidines 
 
Pyrrolizidine nucleus is a very attractive skeleton due to the 
biological importance of molecules containing it. In this line, a 
range of biologically important spiropyrrolizidines 283 and 284 
and pyrrolizinones 286 were reported by Yang et al. The three-
component 1,3-DC of the corresponding 1,3-diketones 282 or 
hydoxycoumarins 285, aromatic aldehyde 20 and proline 1 took 




Scheme 81 Synthesis of functionalized pyrrolizidines 283 and 284 and 
pyrrolizinones 286. 
 
Highly substituted pyrrolizidines 288, bearing multiple 
functionality moieties, were prepared in a multicomponent 1,3-
dipolar cycloaddition.  This simple process involved prolinate 
hydrochlorides 287, aldehydes 20 and the corresponding 
dipolarophiles 124. The reaction proceeded with both high regio- 
and diastereoselectively to yield heterocycles in the presence or 
in the absence of AgOAc as catalyst depending on the aldehyde 
employed (Scheme 82).123 This cascade allowed the access to 
diverse molecular complexity, multiplication of stereocenters 
and access to potential bioactive pyrrolizidine alkaloids. 
 
 
Scheme 82 Synthesis of highly substituted pyrrolizidines 288 via 
multicomponent 1,3-DC. 
 
Another example of the synthesis of trisubstituted pyrrolizidines 
was recently reported via 1,3-DC of nonstabilized azomethine 
ylides and chalcones 289 as electron-deficient dipolarophiles in 
DMF. The reaction proceed regio- and diastereoselectively in a 
one-pot three-component reaction manner obtaining the desired 
compounds 290 together with an oxapyrrolizidine derivative in 
variable proportions. These substituted oxazolidines 291 arose 
when an excess of arylaldehyde 20 was employed, which acted 
as dipolarophile as well (Scheme 83). 124 
 
 
Scheme 83 Preparation of trisubstituted pyrrolizidines 290 and disubstituted 
oxazolidines 291. 
 
A novel one-pot three component iridium catalyzed 
dehydrogenation/1,3-dipolar cycloaddition cascade utilizing 
benzylic alcohols 292 was published. Benzylic alcohols 292, L-
proline 1, and maleimides 94 as dipolarophiles reacted in 
refluxing toluene for 24 h furnishing antimicrobial surrogates 
293 as mixtures of endo/exo-diastereoisomers in good yield 
(Scheme 84).125 
 
Scheme 84 Construction of tricyclic fused ring pyrrolidines 293. 
 
The total synthesis of the proposed structure of yuremamine 296 
was achieved from a [3+2]-cycloaddition of the platinum-
containing azomethine ylide (XIV→XIV’). The spectral data of the 
synthetic sample along with its diastereomers were different 
from the reported one. Lavonoidal skeleton, based on a 
funcionalized pyrrolo[1,2-a]indole core, was achieved with PtCl2 
(5 mol%) and 4A MS from the corresponding imine 294 derived 
from ortho-alkynylanilines. The intermediate platinum-
containing azomethine ylide XIV’ underwent and intermolecular 
1,3-DC with vinyl ether 295. The intermediate platinum carbine 
suffered a 1,2-migration of the substituent (CH2)2OTIPS with 
regeneration of the platinum catalyst to afford the already 
mentioned pyrroloindole skeleton 296 (Scheme 85).126 
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Scheme 85 Synthesis of lavonoidal skeleton of yuremamine 296. 
 
Pandey et al. have recently developed a route to total synthesis of 
both enantiomers of the biologically active (+)-aspidospermidine 
299, whose key step was the preparation of a fused indolizidine 
core through 1,3-DC using a non-stabilized azomethine ylide XV 
from precursor 297.  The enantiomerically pure starting material 
afforded only one diastereoisomer possessing the precise 
absolute configuration in all stereogenic centers (Scheme 86).127 
 
 
Scheme 86 Diastereoselective approach to total synthesis of (+)-
aspidospermidine 299. 
 
Following an intramolecular key 1,3-DC pattern, Fukuyama and 
co-workers accomplished the total synthesis of (-)-daphenylline 
302. The completion of the synthesis of core ABC tricyclic ring 
301 occurred stereospecifically in moderate yield under very 
harsh reaction conditions due to the low activation of the 
dipolarophile present in structure 300. In this example, a 
stabilized azomethine ylide was generated in situ by the iminium 
route (Scheme 87).128 
 
 
Scheme 87 Intramolecular 1,3-DC of  cyclic azomethine ylide employed in the 
synthesis of (+)-daphenylline 302. 
 
Biologically important core intermediates 304 permitted the 
access to extremely complex (±)-caldaphnidine C type alkaloids. 
Bélanger et al. designed a sequential Vilsmeier−Haack (V-H) 
cyclization and intramolecular  1,3-DC of an azomethine ylide 
with an electrophilic alkene as one of the key step of the total 
synthesis. The V-H cyclization occurred rapidly generating an 
iminium salt XVI, which was deprotonated and allowed to react 
with the activated olefin at room temperature in high yields 
(Scheme 88).129  
 
 
Scheme 88 Synthesis of core intermediate to access (±)-caldaphnidine C type 
alkaloid 304. 
 
Recently Brewer et al. have reported an approach to the synthesis 
of the biologically active tricycle, which is the core CDE-ring 
system of the aspidosperma alkaloid family 308. Initially, the 
fragmentation of diazo ester 305 took place using In(OTf)3 under 
mild conditions affording an intermediate stable iminium salt. 
After treatment of 306 with CsF in acetonitrile the tricyclic 
cycloadduct 307 was isolated in good yields as a single 
diastereomer (Scheme 89).130 
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Scheme 89 Ring Fragmentation/Intramolecular Azomethine Ylide 1,3-DC for 
the synthesis of the aspidosperma tricyclic core 308. 
 
Ellman and co-workers described the synthesis of potentially 
bioactive tropanes 310 and 311, and indolizidines 313 and 314 
skeletons through intramolecular 1,3-DC. Non-stabilized 
azomethine ylides, generated from readily prepared 2-
trimethylsilyl-substituted 1,2-dihydropyridines 309 or from  N-
(trimethylsilylmethyl)-1,2-dihydropyridines 312 via 
protonation or alkylation followed by desilylation, were selected 
to react with alkenes or alkynes. In the first example, densely 
substituted tropanes 310 and 311, incorporating quaternary 
carbons, were obtained in good yields and with high regio- and 
stereoselectivities. However, N-trimethylsilylmethyl  derivatives 
312 furnished regio- and diastereoselectively indolizidines 313 
or fused oxazolidine heterocycles 314 depending on the 
dipolarophile employed (Scheme 90).131 These cascades 
represented a powerful approach for the rapid assembly of  
biologically and pharmaceutically relevant nitrogen heterocycle 
scaffolds. Additionally, all these heterocycles reported in this 
work are difficult to synthesize by other methods. The 
implementation of this sequence into the synthesis of natural 
products are underway. 
 
 
Scheme 90 Synthesis of tropanes 310 and 311 and skeletons 313 and 314. 
 
 
7. Synthesis of quinolines and isoquinolines 
 
Tri- and tetra-cyclic pyrrolo/pyrrolizinoquinoline 316 and 318 
were prepared. N-allylated aldehyde 315 and sarcosine 13 
produced tricyclic pyrrolo[3,2-c]quinolines 316 in good yields. 
The analogous reactions were surveyed with proline 1 instead of 
sarcosine 13 and aldehyde 317 giving attractive fused tetracyclic 
pyrrolizinoquinolines 318 with a promising biological potential. 
The reaction afforded the best yields in refluxing acetonitrile 
with a total diastereoselection (Scheme 91).132 
 
 
Scheme 91 Synthesis of tri- and tetracyclic pyrroloquinolines 316 and 318. 
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Biologically important substituted pyrrolo[2,1-a]isoquinolines 
321 were described by Matsuya and co-workers in the presence 
of a [(CyJohnPhos)AuCl/AgOTf] catalytic system in 1,2-
dichloroethane (DCE). In this stereoselective process, a previous 
6-exo-dig-cyclization occurred generating the azomethine ylide 
XVII, which reacted with several dipolaraophiles 124 affording 
pyrroloisoquinoline heterocycles 321 (scheme 92).133 
 
 
Scheme 92 Stereoselective synthesis of pyrrolo[2,1-a]isoquinolines 321. 
 
Chiral pyrroloisoquinolines 327 (X = CH) and pyrrolophthalazine 
327 (X = N) were reported employing an asymmetric inverse-
electron demand 1,3-dipolar cycloaddition of isoquinolinium 
methylides 324 with enecarbamates 325. The catalytic system 
was formed by AgBF4 and a chiral N,N′-dioxide 326. Azomethine 
ylides 324 (isoquinolinium dicyanomethanide or phthalazinium 
dicyanomethanide) were generated from isoquinolines or 
phthalazines 322 and tetracyanoethylene oxide (TCNEO) 323.  
Final fused tricyclic heterocycles 327 were obtained in good to 
excellent chemical yields, high diastereoselections and very good 
enantioselectivities (Scheme 93).134,135 
 
Scheme 93 Enantioselective synthesis tricyclic entities 327. 
 
Biologically active heterocycles 331, containing both indolizines 
and quinoline core structures, were designed by Yavari and co- 
workers. Pyridinium ylides XVIII, generated by an iodine-
mediated reaction of 2-methylquinolines 328 and pyridines 329, 
underwent 1,3-DC with phosphorylated hydroxyketenimines 
330.   This one pot multicomponent cascade process afforded the 
desired heterocycles 331 in good yields (Scheme 94).136 
 
 
Scheme 94 Synthesis of heterocycles 331. 
 
Pyrroloisoquinolines 334 were generated in moderated to high 
yields via 1,3-DC of azomethine  ylide, obtained from 
isoquinolinium salts 332 with substituted ethyl allenoates 333.  
The pyrrole structure was achieved after elimination and 
isomerization occurring during the cycloaddition under basic 
media (Scheme 95).137 The synthetic utility of the cycloaddition 
products 334 can be demonstrated by simple chemical 
manipulations permitting the construction of more sophisticated 
biologically active compounds. 
 
 
Scheme 95 Synthesis of pyrroloisoquinolines 334. 
 
8. Conclusions 
According to all these sections it is reasonable to conclude that 
1,3-DC involving azomethine ylides is a powerful tool in both 
asymmetric or not asymmetric modalities able to give access to a 
wide family of skeletons. The exploration and exploitation of 
their biological activity is preferential for the discovery of new 
applications of the resulting cycloadducts in many scientific 
areas. The scope of theses cycloadditions seems to be unlimited 
and one of main interests of these 1,3-DC is the building of central 
subunits of complex alkaloids in a reduced number of reaction 
steps.   
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